GlassScriptPhysician profile
Scott A Sabo
NPI 1699187039
$5,600.95
in general payments reported to CMS, 2019-2025
29 companies · $927 in 2025
The $927 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,770 · 2020: $203 · 2021: $520 · 2022: $690 · 2023: $325 · 2024: $166 · 2025: $927.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $911 · Travel and Lodging: $507.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $911.18 |
| Travel and Lodging | $506.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Davol INC. | $1,861.60 | 2019-2025 | Phasix Mesh |
| C. R. Bard, INC. & Subsidiaries | $1,199.44 | 2019 | |
| Intuitive Surgical, INC. | $679.05 | 2019-2023 | Da Vinci Surgical System |
| Conmed Corporation | $333.04 | 2019-2022 | |
| Sanara Medtech INC. | $182.63 | 2021 | |
| Wound Management Technologies, INC | $144.21 | 2019 | |
| Kerecis Limited | $133.65 | 2024-2025 | Kerecis Surgiclose, Kerecis Omega3 Marigen, Kerecis Graftguide |
| Misonix INC | $122.12 | 2019 | |
| Ethicon US, LLC | $115.73 | 2024-2025 | Vistaseal, Stratafix, Surgicel Nu-Knit |
| Solventum Corporation | $113.36 | 2024-2025 | Activ.A.C., Activ.A.C. Ion Progress, V.A.C. Veraflo |
| Kci USA, INC. | $83.82 | 2021-2022 | |
| Integra Lifesciences Corporation | $78.81 | 2022-2023 | Integra, Surgimend, Omnigraft |
| Osiris Therapeutics INC. | $78.68 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $77.57 | 2025 | Gattex |
| Avita Medical Americas, LLC | $47.00 | 2025 | Recell, Cohealyx, Permeaderm |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intra-Sana Laboratories | $38.11 | 2021-2024 | Reltone 400 Mg, Reltone 200 Mg, Glycate |
| Smith+Nephew, INC. | $36.01 | 2020 | |
| Abbvie INC. | $35.00 | 2024 | |
| Allergan, INC. | $32.86 | 2022 | |
| Stryker Corporation | $30.84 | 2023 | Spy-Phi System |
| Biocomposites INC | $24.49 | 2025 | Stimulan |
| Medtronic, INC. | $24.24 | 2022 | |
| W. L. Gore & Associates, INC. | $24.09 | 2021 | |
| Mallinckrodt Hospital Products INC. | $22.73 | 2021 | |
| Covidien LP | $20.58 | 2020 | |
| Standard Bariatrics, INC. | $19.05 | 2022 | |
| Phathom Pharmaceuticals, INC. | $15.01 | 2024 | Voquezna |
| Lilly USA, LLC | $13.67 | 2021 | |
| Bioventus LLC | $13.56 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Scott Sabo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.